These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
872 related items for PubMed ID: 19920781
21. Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. Uemura T, Ramprasad V, Matsushima K, Shike H, Valania T, Kwon O, Ghahramani N, Shah R, Farooq U, Khan A, Kadry Z. Transplantation; 2011 Sep 27; 92(6):678-85. PubMed ID: 21841541 [Abstract] [Full Text] [Related]
22. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients. Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC. Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460 [Abstract] [Full Text] [Related]
23. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation. Sampaio MS, Kadiyala A, Gill J, Bunnapradist S. Transplantation; 2009 Oct 15; 88(7):904-10. PubMed ID: 19935462 [Abstract] [Full Text] [Related]
24. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Pilch NA, Taber DJ, Moussa O, Thomas B, Denmark S, Meadows HB, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD. Ann Surg; 2014 May 15; 259(5):888-93. PubMed ID: 24513787 [Abstract] [Full Text] [Related]
25. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells. Morales J, Bono MR, Fierro A, Iñiguez R, Zehnder C, Rosemblatt M, Calabran L, Herzog C, Benavente D, Aguiló J, Pefaur J, Alba A, Ferrario M, Simon W, Contreras L, Buckel E. Transplant Proc; 2008 Nov 15; 40(9):3223-8. PubMed ID: 19010240 [Abstract] [Full Text] [Related]
26. Alemtuzumab induction for retransplantation after primary transplant with alemtuzumab induction . Descourouez JL, Jorgenson MR, Parajuli S, Mandelbrot DA, Leverson GE, Odorico JS, Redfield RR. Clin Nephrol; 2020 Feb 15; 93(2):77-84. PubMed ID: 31670651 [Abstract] [Full Text] [Related]
27. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up. Mangus RS, Fridell JA, Vianna RM, Kwo PY, Chen J, Tector AJ. Liver Transpl; 2012 Jul 15; 18(7):786-95. PubMed ID: 22237953 [Abstract] [Full Text] [Related]
28. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin. Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA. Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977 [Abstract] [Full Text] [Related]
29. Campath induction for kidney transplantation: report of 297 cases. Ortiz J, Palma-Vargas J, Wright F, Bingaman A, Agha I, Rosenblatt S, Foster P. Transplantation; 2008 Jun 15; 85(11):1550-6. PubMed ID: 18551058 [Abstract] [Full Text] [Related]
30. Alemtuzumab induction in kidney transplantation. Huang E, Cho YW, Shah T, Peng A, Hayashi R, Bunnapradist S. Clin Transpl; 2005 Jun 15; ():343-54. PubMed ID: 17424750 [Abstract] [Full Text] [Related]
31. Subcutaneous administration of alemtuzumab in simultaneous pancreas-kidney transplantation. Clatworthy MR, Sivaprakasam R, Butler AJ, Watson CJ. Transplantation; 2007 Dec 27; 84(12):1563-7. PubMed ID: 18165765 [Abstract] [Full Text] [Related]
32. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data. Cai J, Terasaki PI. Transplantation; 2010 Dec 27; 90(12):1511-5. PubMed ID: 21057388 [Abstract] [Full Text] [Related]
33. Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation. Gruessner RW, Kandaswamy R, Humar A, Gruessner AC, Sutherland DE. Transplantation; 2005 May 15; 79(9):1184-9. PubMed ID: 15880067 [Abstract] [Full Text] [Related]
34. Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Pascual J, Mezrich JD, Djamali A, Leverson G, Chin LT, Torrealba J, Bloom D, Voss B, Becker BN, Knechtle SJ, Sollinger HW, Pirsch JD, Samaniego MD. Transplantation; 2007 Jun 15; 83(11):1429-34. PubMed ID: 17565315 [Abstract] [Full Text] [Related]
35. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation. Freise CE, Kang SM, Feng S, Posselt A, Hirose K, Hirose R, Stock P. Transplant Proc; 2004 May 15; 36(4):1067-8. PubMed ID: 15194370 [Abstract] [Full Text] [Related]
37. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes. Trofe-Clark J, Reese PP, Patel HJ, Jakobowski D, Goral S, Doll SL, Abt PL, Bloom RD. Transplantation; 2012 Sep 15; 94(5):506-12. PubMed ID: 22895613 [Abstract] [Full Text] [Related]
38. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression. Miller JT, Collins CD, Stuckey LJ, Luan FL, Englesbe MJ, Magee JC, Park JM. Pharmacotherapy; 2009 Oct 15; 29(10):1166-74. PubMed ID: 19792990 [Abstract] [Full Text] [Related]
39. Alemtuzumab induction in deceased donor kidney transplantation. Huang E, Cho YW, Hayashi R, Bunnapradist S. Transplantation; 2007 Oct 15; 84(7):821-8. PubMed ID: 17984833 [Abstract] [Full Text] [Related]
40. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Eason JD, Loss GE, Blazek J, Nair S, Mason AL. Liver Transpl; 2001 Aug 15; 7(8):693-7. PubMed ID: 11510013 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]